Promethazine Hydrochloride Injection
Links shared publicly online about this topic.
- 1,744total visits
Promethazine Hydrochloride Injection
fda.gov —
View full resource at fda.gov
Tags: Motion Sickness Medication, Nausea and Vomiting Medication, Drug, FDA, Phenergan, Pentazine, Nursing Professions, Nurse
Most Recently Shared on September 17, 2009 at 11:56 pm By:
RT @SafetyNurse Promethazine (Phenergan) gets FDA black box. #nurses #drugs #RT http://bit.ly/106CZB
Also Shared By:
Doxorubicin hydrochloride liposome injection
fda.gov — “News Burst” View full resource at fda.gov
Most Recently Shared on February 21, 2012 at 6:38 pm By:
Today FDA announced major actions taken to bolster supply of Doxil & preservative-free formulations of methotrexate http://t.co/tBxlu57g
Bulletin
ashp.org — “Bulletin” View full resource at ashp.org
Most Recently Shared on December 22, 2011 at 6:58 am By:
December 21st Release- Hydromorphone Hydrochloride Low Potency Injection Shortage http://t.co/flrcFNeg
FDA grants final approval for Mylan's Promethazine HCl Tablets
news-medical.net — “Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Promethazine Hydrochloride (HCl) Tablets USP, 12.5 mg, 25 mg and 50 mg. Promethazine HCl Tablets are used to relieve the symptoms of certain allergic reactions, such as perennial and seasonal allergic rhinitis.” View full resource at news-medical.net
Most Recently Shared on September 9, 2011 at 1:47 pm By:
FDA grants final approval for Mylan's Promethazine HCl Tablets: Mylan Inc. today announced that its subsidiary M... http://t.co/YeLBvqa
APP Pharmaceuticals Announces Approval And Launch Of Clonidine Hydrochloride Injection
medicalnewstoday.com — “APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA)” View full resource at medicalnewstoday.com
Most Recently Shared on July 12, 2011 at 7:05 am By:
APP Pharmaceuticals Announces Approval And Launch Of Clonidine Hydrochloride Injection http://mnt.to/3Y8L #regulatory
Promethazine hydrochloride and dextromethorphan hydrobromide side effect: Alcohol abuse (Alcoholism) by eHealthMe.com
ehealthme.com — “Real world drug outcomes: Alcohol abuse in Promethazine hydrochloride and dextromethorphan hydrobromide. Who have it, when it happens and how? Find it out from a study of Promethazine hydrochloride and dextromethorphan hydrobromide users.” View full resource at ehealthme.com
Most Recently Shared on July 9, 2011 at 5:19 pm By:
Promethazine hydrochloride and dextromethorphan hydrobromide side ... http://bit.ly/p7cXFW
Pfizer Injectables Adds Doxorubicin Hydrochloride Injection, USP To Its Portfolio Of Off-Patent Oncology Products
medicalnewstoday.com — “Pfizer Injectables, part of Pfizer Inc.'s (NYSE: PFE) Established Products Business Unit, announced the addition of doxorubicin hydrochloride injection, USP, to Pfizer Injectables' growing portfol” View full resource at medicalnewstoday.com
Most Recently Shared on June 18, 2011 at 9:09 am By:
Pfizer Injectables Adds Doxorubicin Hydrochloride Injection, USP To Its Portfolio Of Off… http://goo.gl/fb/tdfb8
Non-Sterile Chemotherapy Injections Recalled - EmpowHER.com
empowher.com — “Read about a recall of chemotherapy drugs that were found to be unsanitary.” View full resource at empowher.com
Most Recently Shared on April 1, 2011 at 12:00 am By:
Attn: APP Pharmaceuticals, Inc. is recalling five lots of the #chemotherapy injection Irinotecan Hydrochloride: http://ow.ly/4qCvW
FDA Alert: Irinotecan Hydrochloride Injection: Recall - Fungal Microbial Contaminant
drugs.com — “FDA Alert: Irinotecan Hydrochloride Injection: Recall - Fungal Microbial Contaminant” View full resource at drugs.com
Most Recently Shared on March 29, 2011 at 1:45 am By:
FDA Alert - Recall: Irinotecan Hydrochloride Injection - Fungal Microbial Contaminant - http://bit.ly/ePzpD2
APP Pharmaceuticals Recalls Irinotecan Hydrochloride Injections
usrecallnews.com — “APP Pharmaceuticals, is re recalling five lots of Irinotecan Hydrochloride Injection, which is used for recurrent or progressive metastatic colorectal cancer.” View full resource at usrecallnews.com
Most Recently Shared on March 28, 2011 at 7:42 pm By:
APP Pharmaceuticals Recalls Irinotecan Hydrochloride Injections http://f.ast.ly/ssMYY
FDA MedWatch - Irinotecan Hydrochloride Injection: Recall - Fungal Microbial Contaminant - Drugs.com MedNews
drugs.com — “AUDIENCE Oncology, Pharmacy, Risk Manager ISSUE APP Pharmaceuticals, Inc. issued a voluntary recall of five lots of Irinotecan Hydrochloride Injection due to th” View full resource at drugs.com
Most Recently Shared on March 28, 2011 at 5:06 pm By:
FDA MedWatch - Irinotecan Hydrochloride Injection: Recall - Fungal Microbial Contaminant: AUDIENCE: Oncolo... http://bit.ly/fhbqSE #drug
APP recalls five lots of colorectal cancer drug | HemOncToday
hemonctoday.com — “Five lots of irinotecan hydrochloride injection were voluntarily recalled by manufacturer APP Pharmaceuticals, Inc. as a precautionary measur” View full resource at hemonctoday.com
Most Recently Shared on March 28, 2011 at 3:19 pm By:
APP recalls five lots of colorectal cancer drug http://bit.ly/i3EPtW
APP Pharmaceuticals Issues A Nationwide Voluntary Recall Of Irinotecan Hydrochloride Injection
medicalnewstoday.com — “APP Pharmaceuticals, Inc., (APP) announced that it has issued a voluntary recall of five lots of Irinotecan Hydrochloride Injection, which is used for recurrent or progressive metastatic colorecta” View full resource at medicalnewstoday.com
Most Recently Shared on March 28, 2011 at 9:05 am By:
APP Pharmaceuticals Issues A Nationwide Voluntary Recall Of Irinotecan Hydrochloride Injection http://mnt.to/3SNx #colorectalcancer
Eisai Marks Fully-fledged Entry into Japanese Oncology Market with Launch of Anticancer Agent Treakisym Injection 100 MG - Drugs.com MedNews
drugs.com — “TOKYO, Dec 10, 2010 - (JCN Newswire) - Eisai Co., Ltd. today launched the anticancer agent Treakisym Injection 100 mg (bendamustine hydrochloride) in Japan as a” View full resource at drugs.com
Most Recently Shared on December 10, 2010 at 3:13 pm By:
Eisai Marks Fully-fledged Entry into Japanese Oncology Market with Launch of Anticancer Agent Treakisym In... http://bit.ly/f6g2Dc #drug
Sagent launches chemotherapy agent topotecan hydrochloride for injection
news-medical.net — “Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced U.S. FDA approval and launch of its topotecan hydrochloride for injection, a chemotherapy agent, in conjunction with the innovator's patent expiry. Sagent's topotecan is available in 4 mg single-dose latex-free vials.” View full resource at news-medical.net
Most Recently Shared on December 3, 2010 at 9:10 am By:
Oncology News: Sagent launches chemotherapy agent topotecan hydrochloride for injection: Sagent Pharmaceuticals,... http://bit.ly/hpKyDG
Astellas suspends patient enrollment from ACT 5 study of KYNAPID
news-medical.net — “Cardiome Pharma Corp. today announced that its co-development partner, Astellas Pharma US., Inc., has suspended patient enrollment in the ACT 5 study of KYNAPIDTM (vernakalant hydrochloride) Injection following a single unexpected serious adverse event of cardiogenic shock experienced by a patient with atrial fibrillation who received KYNAPID.” View full resource at news-medical.net
Most Recently Shared on October 22, 2010 at 9:39 am By:
Astellas suspends patient enrollment from ACT 5 study of KYNAPID: Cardiome Pharma Corp. today announced that its c... http://bit.ly/afLowq
Advertisement





Barbara Olson
@SafetyNurse
Promethazine (Phenergan) gets FDA black box. #nurses #drugs #RT http://bit.ly/106CZB
1 year ago...